1 – 10 of 13
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
In Vitro Elimination of Highly Multidrug-Resistant Bacteria by the Lactic Acid Bacterial Drug Candidate ILP100
- Contribution to journal › Article
- 2024
-
Mark
Agonist antibody to guanylate cyclase receptor NPR1 regulates vascular tone
- Contribution to journal › Article
- 2021
-
Mark
Ultra-rare sarcomas: A consensus paper from the Connective Tissue Oncology Society community of experts on the incidence threshold and the list of entities
- Contribution to journal › Article
-
Mark
Ligand-protein interactions of plant-isolated (9z,12z)-octadeca-9,12-dienoic acid with Β-ketoacyl-Acp synthase (KasA) in potential anti-tubercular drug designing
- Contribution to journal › Article
- 2020
-
Mark
Impact of COVID-19 in paediatric early-phase cancer clinical trials in Europe : A report from the Innovative Therapies for Children with Cancer (ITCC) consortium
- Contribution to journal › Article
-
Mark
Dyskinesia matters
- Contribution to journal › Article
-
Mark
Improved infrastructure and support needed for paediatric clinical trials in Sweden
- Contribution to journal › Article
- 2018
-
Mark
Mitochondrial medicine. New strategies to evaluate drug toxicity and develop pharmacological protection of the cell’s powerhouse.
(2018)
- Thesis › Doctoral thesis (compilation)
- 2017
-
Mark
Phage display and kinetic selection of antibodies that specifically inhibit amyloid self-replication
(2017) In Proceedings of the National Academy of Sciences of the United States of America 114(25). p.6444-6449
- Contribution to journal › Article
-
Mark
Societal challenges of precision medicine : Bringing order to chaos
- Contribution to journal › Article
